Profil
Dr. Sebastien Hazard was previously employed as a Chief Medical Officer & Executive Vice President by Imunon, Inc., a Senior VP & Head-Clinical Development by Bicycle Therapeutics Plc, a Head-Clinical Development by GlaxoSmithKline Plc, and a Senior Medical Director-Clinical Development by Tesaro, Inc. He received his MBA from INSEAD.
Ehemalige bekannte Positionen von Sebastien Hazard
| Unternehmen | Position | Ende |
|---|---|---|
| BICYCLE THERAPEUTICS PLC | Corporate Officer/Principal | 01.09.2023 |
| GSK PLC | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2021 |
| TESARO INC | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2019 |
| IMUNON, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Sebastien Hazard
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Imunon, Inc.
Imunon, Inc. BiotechnologyHealth Technology Engages in the provision of oncology drug development services | Health Technology |
Tesaro, Inc.
Tesaro, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for cancer patients | Health Technology |
GSK Plc
GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
INSEAD
INSEAD Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bicycle Therapeutics Plc
Bicycle Therapeutics Plc Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops molecules and oncology medicines | Health Technology |
















